Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,170 public trials 550 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults

NCT02178800

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Bridge HIV CRS San Francisco, California, United States
  • George Washington Univ. CRS Washington D.C., District of Columbia, United States
  • Chapel Hill CRS Chapel Hill, North Carolina, United States
View Trial Details
Completed

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

NCT01376726

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States
  • Seattle Vaccine and Prevention CRS Seattle, Washington, United States
View Trial Details
Completed

Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection

NCT01587586

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Changhua Christian Hospital Changhua, Taiwan
  • National Taiwan University Hospital - Yunlin Douliu, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Chang Gung Medical Foundation - Kaohsiung Kaohsiung City, Taiwan
View all 13 locations
View Trial Details
Completed

Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B

NCT00007332

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • San Francisco Dept. of Public Health, San Francisco Gen. Hosp. San Francisco, California, United States
  • San Francisco Vaccine and Prevention CRS San Francisco, California, United States
  • Project Brave HIV Vaccine CRS Baltimore, Maryland, United States
View all 17 locations
View Trial Details
Completed

Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults

NCT00413725

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Soweto HVTN CRS Johannesburg, Gauteng, South Africa
  • MedCRU CRS Pretoria, Gauteng, South Africa
  • eThekwini CRS Durban, KwaZulu-Natal, South Africa
  • Emavundleni CRS Cape Town, Western Cape, South Africa
View Trial Details
Completed

Evaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected Adults

NCT02165267

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • Fenway Health (FH) CRS Boston, Massachusetts, United States
  • Columbia P&S CRS New York, United States
  • New York Blood Center CRS New York, United States
View Trial Details
Completed

Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults

NCT01578889

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Columbia P&S CRS New York, United States
  • New York Blood Center CRS New York, United States
  • University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States
  • Penn Prevention CRS Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults

NCT01479296

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Bridge HIV CRS San Francisco, California, United States
  • UIC Project WISH CRS Chicago, Illinois, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • Columbia P&S CRS New York, United States
View Trial Details

Related conditions